FR2445146B1 - - Google Patents

Info

Publication number
FR2445146B1
FR2445146B1 FR7931087A FR7931087A FR2445146B1 FR 2445146 B1 FR2445146 B1 FR 2445146B1 FR 7931087 A FR7931087 A FR 7931087A FR 7931087 A FR7931087 A FR 7931087A FR 2445146 B1 FR2445146 B1 FR 2445146B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7931087A
Other versions
FR2445146A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
A Natterman und Cie GmbH
Original Assignee
A Natterman und Cie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Natterman und Cie GmbH filed Critical A Natterman und Cie GmbH
Publication of FR2445146A1 publication Critical patent/FR2445146A1/fr
Application granted granted Critical
Publication of FR2445146B1 publication Critical patent/FR2445146B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
FR7931087A 1978-12-27 1979-12-19 Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides Granted FR2445146A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2856333A DE2856333C2 (de) 1978-12-27 1978-12-27 Oral einnehmbare Arzneimittel mit entzündungshemmender Wirkung

Publications (2)

Publication Number Publication Date
FR2445146A1 FR2445146A1 (fr) 1980-07-25
FR2445146B1 true FR2445146B1 (fr) 1983-09-02

Family

ID=6058494

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7931087A Granted FR2445146A1 (fr) 1978-12-27 1979-12-19 Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides

Country Status (13)

Country Link
US (1) US4332795A (fr)
JP (1) JPS5589225A (fr)
AT (1) AT369654B (fr)
BE (1) BE880830A (fr)
CA (1) CA1133395A (fr)
CH (1) CH643739A5 (fr)
DE (1) DE2856333C2 (fr)
FR (1) FR2445146A1 (fr)
GB (1) GB2039738B (fr)
IT (1) IT1164550B (fr)
NL (1) NL7909244A (fr)
SE (1) SE448603B (fr)
ZA (1) ZA797008B (fr)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2914789A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Injizierbare arzneimittel mit entzuendungshemmender wirkung
DE2914788A1 (de) * 1979-04-11 1980-10-16 Nattermann A & Cie Parenteral applizierbare, stabile arzneimittelloesungen mit entzuendungshemmender wirkung
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
EP0092121B1 (fr) * 1982-04-12 1987-12-16 Board Of Regents, The University Of Texas System Méthodes et compositions pour traiter les ulcères gastro-intestinaux
GB2119244A (en) * 1982-04-30 1983-11-16 Alza Corp Potassium replacement therapy
US4666893A (en) * 1983-02-15 1987-05-19 St. Thomas Institute Methods of inducing resistance to bacterial and viral infections
CA1237670A (fr) * 1983-05-26 1988-06-07 Andrew S. Janoff Reduction de la toxicite de certains medicaments
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
DE3346525A1 (de) * 1983-12-22 1985-07-04 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutische zubereitung mit speziellen 1,2-diacyl-glycero-3-phosphocholinen zur behandlung von erkrankungen im magen-darmbereich
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US5283067A (en) * 1987-01-30 1994-02-01 Ciba-Geigy Corporation Parenteral suspensions
US5043329A (en) * 1987-02-17 1991-08-27 Board Of Regents, University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US4950656A (en) * 1987-02-17 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
US5260284A (en) * 1987-02-17 1993-11-09 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids and sterol for lung surfactant replacement therapy
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5091187A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5763422A (en) * 1995-01-27 1998-06-09 Board Of Regents, The University Of Texas System Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
US5955451A (en) * 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
DE69637441T2 (de) 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
AUPN766496A0 (en) * 1996-01-22 1996-02-15 University Of New England, The Method and composition for the potentiation of anti-inflammatory drugs
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CA2320807C (fr) * 1998-02-11 2011-01-18 Research Triangle Pharmaceuticals Procede et composition de traitement d'etats inflammatoires
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
ES2211151T3 (es) 1998-08-19 2004-07-01 Skyepharma Canada Inc. Dispersiones acuosas inyectables de propofol.
SK288117B6 (sk) 1998-11-20 2013-09-03 Skyepharma Canada Inc. Rapidly dispersing solid dry therapeutic dosage form
WO2001021154A2 (fr) * 1999-09-21 2001-03-29 Rtp Pharma Inc. Compositions particulaires, a surface modifiee, de substances biologiquement actives
JP5102423B2 (ja) 2000-04-20 2012-12-19 オバン・エナジー・リミテッド 改善された水不溶性薬剤粒子の処理
ATE424811T1 (de) 2000-08-31 2009-03-15 Jagotec Ag Gemahlene partikel
US8586094B2 (en) * 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
US20020058065A1 (en) * 2000-09-20 2002-05-16 Pol-Henri Guivarc'h Insoluble drug particle compositions with improved fasted-fed effects
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
US20100173876A1 (en) * 2000-12-19 2010-07-08 The Board Of Regents Of The University Of Texas System Oil-based nsaid compositions and methods for making and using same
US6534088B2 (en) * 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
WO2013049749A2 (fr) 2011-09-29 2013-04-04 Plx Pharma Inc. Vecteurs dépendant du ph pour libération ciblée de produits pharmaceutiques dans le tube digestif, compositions préparées à partir de ceux-ci, et leur fabrication et leur utilisation
WO2016185816A1 (fr) * 2015-05-18 2016-11-24 不二製油グループ本社株式会社 COMPOSITION D'ADDITIF ALIMENTAIRE AYANT UN EFFET DE SUPPRESSION DE PRODUCTION DE IL-1β
WO2021195319A1 (fr) 2020-03-26 2021-09-30 Plx Opco Inc. Supports pharmaceutiques aptes à la reconstitution dépendante du ph et leurs procédés de fabrication et d'utilisation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL32337C (fr) *
IT1044768B (it) * 1969-04-03 1980-04-21 Italeapmaco Spa Supposte contenenti un principio attivo ascorbato di aminofemazione liofilizzato e processo per la loro preparazione

Also Published As

Publication number Publication date
GB2039738B (en) 1983-04-13
SE448603B (sv) 1987-03-09
NL7909244A (nl) 1980-07-01
CA1133395A (fr) 1982-10-12
IT7928358A0 (it) 1979-12-21
JPS5589225A (en) 1980-07-05
JPS6320209B2 (fr) 1988-04-26
CH643739A5 (de) 1984-06-29
BE880830A (fr) 1980-04-16
US4332795A (en) 1982-06-01
SE7910371L (sv) 1980-06-28
ZA797008B (en) 1980-12-31
DE2856333C2 (de) 1983-09-22
AT369654B (de) 1983-01-25
IT1164550B (it) 1987-04-15
GB2039738A (en) 1980-08-20
ATA808379A (de) 1982-06-15
FR2445146A1 (fr) 1980-07-25
DE2856333A1 (de) 1980-08-21

Similar Documents

Publication Publication Date Title
AU3898778A (fr)
AU3803078A (fr)
AU73950S (fr)
AU3892778A (fr)
BG26014A1 (fr)
BG25918A1 (fr)
BE871570A (fr)
BG25806A1 (fr)
BG25814A2 (fr)
BG25816A1 (fr)
BG25818A1 (fr)
BG25835A1 (fr)
BG25836A1 (fr)
BG25842A1 (fr)
BG25843A1 (fr)
BG25849A1 (fr)
BG25854A1 (fr)
BG25857A1 (fr)
BG25858A1 (fr)
BG25871A1 (fr)
BG25872A1 (fr)
BG26015A1 (fr)
BG25875A1 (fr)
BG25879A1 (fr)
BG25889A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse